Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player


The company has initiated and in process to start of production facilities as per PIC/S guidelines for oral and injectables dosage along with Lyophilization in the therapeutic segment of Oncology.

The company has developed certain new formulations under the segment of Antiretrovirals and Immunosuppressants.

The plant of the company and its associates are undergoing inspection for approval of PIC/S certification.

No Name No Name
   1 Antihypertensives   11 Antiemetics
   2 Antiulcerant   12 Antipsychotics
   3 Antiallergics   13 Antirheumatoid
   4 Antibacterials   14 Antispasmodics
   5 Antidepressant   15 Corticosteroid
   6 Antifungal   16 Haemostatics
   7 Antihelmintics   17 Antiretroviral
   8 Antihistamines & Anticold   18 Nutrional Supplement
   9 Antimalarials   19 Antituberculosis
   10 Antineoplastic / Anticancer   20 Immunosuppressant
Strength: 10mg & 20mg
Dosage: Tablets
Indication: Rheumatic Disorders, Ophthalmic Diseases Severe acute and chronic allergic.
Methyl Prednisolone
Strength: 20mg, 40mg, 125mg, 250mg & 500mg
Dosage: Dry Powder Injection
Indication: Acute Spinal cord Injury, Acute Status Asthmaticus & Hematological Disorders
Prednisolone Sodium Phosphate
Strength: 5mg /5ml
Dosage: Suspension
Indication: - It is indicated in the following conditions:- Allergics States, Dermatologic , Gastrointestinal, Neoplastic , Respiratory diseases, Nervous System and Endocrine, Hematologic, Rheumatic disorders.
Prednisolone Sodium Phosphate
Strength: 30mg/ml
Dosage: liquid Injection
Indication: Rheumatic Disorders , Ophthalmic Diseases Severe acute and chronic allergic.
© 2009 Lok Beta Pvt. Ltd. All rights reserved.
Sitemap   |   Privacy Policy   |   Credits